The Statistical Nature of AI Confabulation and the Physician Backstop
Reading Time: 5 minutesA physician's read on how AI hallucinations actually show up in clinic, and why 'confident wrong' is the failure mode we don't talk about enough.
How orforglipron, semaglutide, and tirzepatide are reshaping primary-care prescribing — read in plain English by a working physician.
52 stories · Updated May 28, 2026
Reading Time: 5 minutesA physician's read on how AI hallucinations actually show up in clinic, and why 'confident wrong' is the failure mode we don't talk about enough.
Reading Time: 8 minutesA wrongful death lawsuit against OpenAI exposes the dangers of consumer chatbots giving medical advice. Physicians must understand these risks to protect patients.
Reading Time: 9 minutesViz.ai has launched a new platform to accelerate pulmonary embolism triage. We review the clinical evidence behind AI in pulmonary care and its impact on intervention times.
Reading Time: 9 minutesState-level price caps on GLP-1 medications are reshaping metabolic health treatment. This review covers how Maryland's recent cap on Ozempic affects your prescribing workflows and patient access.